Stenhouse Mark
Insider CIK 1734751 · EXAS President, Cologuard · RXDX Chief Operating Officer · PHAT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHAT Phathom Pharmaceuticals, I | A Award | 2026-05-19 | 2026-05-21 | 24,122 | — | $0 | 54,122 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2025-06-03 | 2025-06-05 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2025-06-03 | 2025-06-05 | 10,500 | — | $0 | 30,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2024-05-23 | 2024-05-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2024-05-23 | 2024-05-24 | 10,500 | — | $0 | 19,500 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 86,582 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 34,085 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 70,371 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 240,000 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 40,000 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer | 2023-06-16 | 2023-06-16 | 12,754 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer | 2023-06-16 | 2023-06-16 | 14,000 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | J Other | 2023-06-01 | 2023-06-02 | 14,000 | — | $0 | 12,708 | SEC↗ |
| RXDX Prometheus Biosciences, In | J Other | 2023-06-01 | 2023-06-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2023-05-25 | 2023-05-30 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RXDX Prometheus Biosciences, In | A Award deriv | 2022-12-09 | 2022-12-13 | 34,085 | — | $0 | 34,085 | SEC↗ |
| RXDX Prometheus Biosciences, In | A Award | 2022-12-09 | 2022-12-13 | 9,811 | — | $0 | 26,442 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2022-05-25 | 2022-05-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RXDX Prometheus Biosciences, In | A Award deriv | 2022-05-20 | 2022-05-20 | 86,582 | — | $0 | 86,582 | SEC↗ |
| RXDX Prometheus Biosciences, In | A Award deriv | 2021-11-14 | 2021-11-16 | 70,371 | — | $0 | 70,371 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2021-05-21 | 2021-05-24 | 12,500 | — | $0 | 12,500 | SEC↗ |
| RXDX Prometheus Biosciences, In | P Buy | 2021-03-16 | 2021-03-16 | 14,000 | $19.00 | $266.0K | 14,000 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-04-03 | 2020-04-06 | 11,948 | $56.69 | $677.3K | 29,571 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2020-04-02 | 2020-04-06 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2020-04-02 | 2020-04-06 | 25,000 | — | $0 | 41,519 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2020-03-17 | 2020-03-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2020-02-27 | 2020-02-28 | 1,051 | $80.27 | $84.4K | 16,519 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2020-02-26 | 2020-02-28 | 3,262 | — | $0 | 9,789 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2020-02-26 | 2020-02-28 | 3,262 | — | $0 | 17,570 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2020-02-14 | 2020-02-18 | 11,445 | — | $0 | 11,445 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2020-02-14 | 2020-02-18 | 14,123 | — | $0 | 14,123 | SEC↗ |
| EXAS EXACT SCIENCES CORP | S Sale | 2019-04-03 | 2019-04-04 | 11,192 | $92.54 | $1.04M | 14,308 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise deriv | 2019-04-02 | 2019-04-04 | 25,000 | — | $0 | 50,000 | SEC↗ |
| EXAS EXACT SCIENCES CORP | M Exercise | 2019-04-02 | 2019-04-04 | 25,000 | — | $0 | 25,500 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2019-02-26 | 2019-02-28 | 13,051 | — | $0 | 13,051 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2019-02-26 | 2019-02-28 | 10,786 | — | $0 | 10,786 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award deriv | 2018-04-02 | 2018-04-03 | 75,000 | — | $0 | 75,000 | SEC↗ |